93 related articles for article (PubMed ID: 20691472)
1. Smudge cells: very old history and new conclusions.
Paydas S
Leuk Res; 2010 Dec; 34(12):1680. PubMed ID: 20691472
[No Abstract] [Full Text] [Related]
2. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.
Johansson P; Eisele L; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J; Nückel H
Leuk Res; 2010 Jul; 34(7):892-8. PubMed ID: 20353875
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic value of smudge cells (Gumprecht shadows) in chronic lymphocytic leukaemia].
Szerafin L; Jakó J; Riskó F; Hevessy Z
Orv Hetil; 2012 Nov; 153(44):1732-7. PubMed ID: 23103742
[TBL] [Abstract][Full Text] [Related]
4. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
[TBL] [Abstract][Full Text] [Related]
5. A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.
Hassanein NM; Perkinson KR; Alcancia F; Goodman BK; Weinberg JB; Lagoo AS
Am J Clin Pathol; 2010 May; 133(5):708-17. PubMed ID: 20395517
[TBL] [Abstract][Full Text] [Related]
6. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
8. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
Rivkina A; Vitols G; Murovska M; Lejniece S
Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
[TBL] [Abstract][Full Text] [Related]
9. Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia.
Röth A; de Beer D; Nückel H; Sellmann L; Dührsen U; Dürig J; Baerlocher GM
Br J Haematol; 2008 Nov; 143(3):383-6. PubMed ID: 18759763
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.
Del Principe MI; Del Poeta G; Venditti A; Buccisano F; Maurillo L; Marini R; Cox MC; Panetta P; Suppo G; Degan M; Bruno A; Gattei V; Amadori S
Haematologica; 2004 Dec; 89(12):1468-75. PubMed ID: 15590397
[TBL] [Abstract][Full Text] [Related]
11. Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome.
Rossi D; Bodoni CL; Zucchetto A; Rasi S; De Paoli L; Fangazio M; Rossi FM; Ladetto M; Gattei V; Gaidano G
Am J Hematol; 2010 Aug; 85(8):619-22. PubMed ID: 20578200
[No Abstract] [Full Text] [Related]
12. Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia.
Gangemi S; Allegra A; Alonci A; Pace E; Ferraro M; Cannavò A; Penna G; Saitta S; Gerace D; Musolino C
Blood Cells Mol Dis; 2013 Jan; 50(1):39-40. PubMed ID: 22909798
[No Abstract] [Full Text] [Related]
13. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
[TBL] [Abstract][Full Text] [Related]
14. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).
Del Giudice I; Davis Z; Matutes E; Osuji N; Parry-Jones N; Morilla A; Brito-Babapulle V; Oscier D; Catovsky D
Leukemia; 2006 Jul; 20(7):1231-7. PubMed ID: 16642047
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
Orlandi EM; Bernasconi P; Pascutto C; Giardini I; Cavigliano PM; Boni M; Zibellini S; Cazzola M
Hematol Oncol; 2013 Sep; 31(3):136-42. PubMed ID: 23060227
[TBL] [Abstract][Full Text] [Related]
16. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
[TBL] [Abstract][Full Text] [Related]
17. CD38 Expression and Variation as a Prognostic Factor Chronic Lymphocytic Leukemia.
Falay M; Ceran F; Gunes AK; Dagdas S; Ayli M; Ozet G
Clin Lab; 2016 Jul; 62(7):1287-1293. PubMed ID: 28164634
[TBL] [Abstract][Full Text] [Related]
18. CD38+ chronic lymphocytic leukaemia cells co-express high levels of ZAP-70 and are functionally distinct from their CD38- counter-parts.
Pepper C; Brennan P; Alghazal S; Ward R; Pratt G; Starczynski J; Lin T; Rowntree C; Fegan C
Leukemia; 2006 Apr; 20(4):743-4. PubMed ID: 16452999
[No Abstract] [Full Text] [Related]
19. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
20. Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.
Nowakowski GS; Hoyer JD; Shanafelt TD; Geyer SM; LaPlant BR; Call TG; Jelinek DF; Zent CS; Kay NE
Mayo Clin Proc; 2007 Apr; 82(4):449-53. PubMed ID: 17418074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
